C. Brock
- Genetics top 1%
- Glioma Diagnosis and Treatment 8
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 5
- Cancer, Hypoxia, and Metabolism 4
-
- Brain Metastases and Treatment 2
-
- Medical Imaging Techniques and Applications 6
- Radiopharmaceutical Chemistry and Applications 3
- Oncology top 10%
-
- Testicular diseases and treatments 4
-
- Gestational Trophoblastic Disease Studies 3
- Co-authors
- E.S. NewlandsStephen R. WedgeM. F. G. STEVENSRichard T. WheelhouseMark BowerGordon RustinHelen EvansM.G. Glaser
- Journals
- British Journal of Cancer (5 papers)Journal of Clinical Oncology (4 papers)European Journal of Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
C. Brock
31 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Genetics 656
- Cancer Research 233
- Pulmonary and Respiratory Medicine 431
- Radiology, Nuclear Medicine and Imaging 297
- Oncology 347
Countries citing papers authored by C. Brock
This map shows the geographic impact of C. Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Brock more than expected).
Fields of papers citing papers by C. Brock
This network shows the impact of papers produced by C. Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Brock. The network helps show where C. Brock may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Brock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 2 | |
| 3 | 2006 | 16 | |
| 4 | 2005 | 15 | |
| 5 | 2004 | 15 | |
| 6 | 2004 | 10 | |
| 7 | 2003 | 76 | |
| 8 | 2002 | 23 | |
| 9 | 2002 | 1 | |
| 10 | 2001 | 60 | |
| 11 | Does technetium-99m sestamibi (MIBI) scintimammography predict breast tumour response to anthracycline-based chemotherapy? | 2000 | 1 |
| 12 | 2000 | 86 | |
| 13 | 1999 | 54 | |
| 14 | Phase I trial of temozolomide using an extended continuous oral schedule. | 1998 | 228 |
| 15 | 1997 | 12 | |
| 16 | Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trialsbreakdown → | 1997 | 631 |
| 17 | 1997 | 7 | |
| 18 | 1997 | 231 | |
| 19 | 1996 | 122 | |
| 20 | 1995 | 4 |
About C. Brock
C. Brock is a scholar working on Genetics, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 33 papers that have together received 1.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (8 papers), Medical Imaging Techniques and Applications (6 papers), Cancer Genomics and Diagnostics (5 papers), Testicular diseases and treatments (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Gestational Trophoblastic Disease Studies (3 papers) and Brain Metastases and Treatment (2 papers). The work is most often cited by research in Genetics (656 citations), Cancer Research (233 citations) and Pulmonary and Respiratory Medicine (431 citations). C. Brock has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include E.S. Newlands, Stephen R. Wedge, M. F. G. STEVENS, Richard T. Wheelhouse, Mark Bower, Gordon Rustin, Helen Evans, M.G. Glaser, Iain Colquhoun and L. Holden. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, European Journal of Cancer, Neuroradiology and Oncogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.